Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Acne is an important sign of androgen excess disorders in women.

Obese and non-obese women with PCOS have higher heart risk markers, especially if they are obese.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

Sexual orientation does not affect the prevalence of PCOS or fertility rates in women undergoing artificial donor insemination.

A woman developed male traits from accidental contact with her husband's testosterone gel.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Minoxidil and finasteride can help with hair loss, but more research is needed to improve treatments for certain types of hair loss.

Aldactone was more effective in reducing hair growth in women with hirsutism than Diane, despite having less impact on hormone levels.

AI can improve early diagnosis and classification of PCOS, aiding in prevention of related health issues.

Oriental herbal medicine with moxibustion may improve pregnancy rates and other symptoms in PCOS, but more high-quality research is needed.

High levels of male hormones are very common in women with PCOS and affect their metabolism differently depending on their weight.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

DA-9401 helps protect rat testis from finasteride damage.

The document concludes that diagnosing PCOS in teenagers is difficult and should focus on specific hormone levels and menstrual irregularities, while also considering treatment for symptoms and related health issues.

Women with PCOS have higher levels of a certain growth factor, which can be reduced by taking metformin.

The research suggests that the ZP4 gene is linked to egg development in women with PCOS but requires more study to understand its role in infertility.

Metformin helps regulate menstrual cycles, induce ovulation, and improve pregnancy outcomes in women with PCOS.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

COVID-19 may harm male fertility and damage the reproductive system.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Selenium might help with insulin resistance and cholesterol in PCOS, but more research is needed to confirm its benefits.